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Summary Statement 
 
The electrophysiology of MacTel is consistent with a central localized disorder and an 
inner retinal site of dysfunction 
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Abstract 
 
Purpose 
To investigate the electrophysiological features of Macular Telangiectasia (MacTel) 
type 2 and their relationship to structure as determined by optical coherence 
tomography (OCT) imaging.  
 
Methods 
Forty-two eyes from 21 patients enrolled in the MacTel Natural History Observation 
Study were reviewed. All patients had full-field and pattern electroretinography 
(ERG; PERG) with some patients additionally having multifocal electroretinography 
(mfERG; N=15) or electrooculography (EOG; N=12). Multiple linear regression 
modelling assessed the relationship between the ellipsoid zone (EZ) break size on 
OCT and the central mfERG response.  
 
Results 
Full-field ERG and EOG were normal in all eyes. Six eyes (14%) from 5 patients had 
subnormal PERG P50 amplitudes. Twenty-two of 30 eyes (73%) had reduced central 
or paracentral stimulus on mfERG. There was a significant correlation between EZ 
break size and both the P1 amplitude (R2 = 0.37, p = 0.002) and P1:N1 ratio (R2 = 
0.32, p = 0.002) of the central response on mfERG.  
 
Conclusion 
The electrophysiological findings in MacTel type 2 are those of localized central 
dysfunction and are consistent with the structural data available from imaging and 
 4 
histological studies. The EZ break size correlates with mfERG reduction. The reduced 
mfERG P1:N1 ratio is consistent with inner retinal dysfunction.  
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Introduction 
Macular telangiectasia (MacTel) type 2 is a bilateral slowly progressive disease of 
unclear aetiology characterized by macular neuro-degeneration and vascular 
alterations.1 Typical fundoscopic findings include perifoveal graying, ectatic 
capillaries and crystalline deposits, with intraretinal pigment migration occurring in 
later stages.2 Recent advances in multimodal imaging techniques have provided 
further morphologic characterization with evidence of hyporeflective spaces and outer 
retinal atrophy on optical coherence tomography (OCT), abnormal distribution of 
macula pigment on dual wavelength autofluoresence and increased parafoveal area of 
reflectance on blue light reflectance (BLR) imaging.1,3–6 Emerging understanding from 
histological studies have pointed to localized Müller cell dysfunction and 
photoreceptor cell loss as central to this disorder.7  
 
The onset of symptoms typically occurs in the fifth decade, with decline in visual 
acuity, development of paracentral scotomata and reading difficulty being 
predominant features.8–10 Patients report a significant impact on vision-related quality 
of life early in disease, despite relatively preserved binocular distance visual 
acuity.8,11,12 Psychophysical assessment of function with fundus-controlled perimetry 
(microperimetry) in mesopic conditions has identified paracentral localized 
scotomata.10,13 Fine matrix mapping has also been used to study scotopic function, 
with the suggestion of greater macular rod than macular cone dysfunction in 
MacTel.14,15 However, microperimetry and fine matrix mapping are subjective and not 
widely available and little is known on more objective electrophysiological measures.  
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Reduction in the full-field electroretinogram (ERG) responses from baseline was used 
as a primary safety outcome marker in a recent phase I trial for MacTel with a ciliary 
neurotrophic factor intraocular implant.16 Electrophysiological characterization of 
MacTel has otherwise been limited.17–19 The present study reports the 
electrophysiological characteristics in patients with MacTel in detail and examines 
possible structure/function correlation between spectral domain OCT (SD-OCT) and 
electrophysiological parameters.  
 
Methods 
Study Design 
A retrospective review of patients diagnosed with MacTel type 2 at Moorfields Eye 
Hospital, London, UK, and who were enrolled as participants in the international 
MacTel Natural History Observation Study or MacTel Registry study. The protocol 
has been previously published with confirmation of disease status based on 
characteristic fundoscopy, SD-OCT, autofluorescence and fluorescein angiographic 
features.20 All patients on the registry, who also had electrophysiology studies as part 
of their diagnostic work up, were identified from the hospital electronic database. 
Participants with other significant ocular comorbidities or with exposure to 
medications known to cause retinal or optic nerve toxicity were excluded from the 
analysis. The study was conducted according to the tenets of the Declaration of 
Helsinki and written informed consent was obtained from all patients. 
  
Electrophysiology 
 
 7 
All patients underwent electrophysiological assessment using full-field and pattern 
electroretinography (ERG; PERG), recorded with gold foil electrodes. Pattern ERGs 
were recorded to a standard stimulus field (15 x 11 degrees) and additionally to a 
large stimulus field (30 x 22 degrees); check size was 0.8 degrees.21 
Electrophysiological responses were compared with age-matched normal values and 
additionally for a normal level of inter-ocular symmetry (<30% difference in 
amplitude). A subset of patients additionally underwent multifocal ERG (mfERG) and 
electrooculography (EOG); this was not primarily related to clinical features, and was 
usually dependant upon availability of test facilities when the patient attended, but 
occasionally mfERG was performed if there was clinical suspicion of macular 
pathology but the initial PERG was normal. Protocols incorporated the standards of 
the International Society for Clinical Electrophysiology of Vision.22–25  Multifocal 
ERG (RETIscan, Roland Consult, Germany) was recorded to a scaled 61 element 
stimulus array. The N1 (first negative) and P1 (first positive) components of the first 
order kernel responses were individually analyzed for the foveal field (R1) as well as 
the average of each of the concentric rings (R2 - 5). Paracentral responses just 
temporal and nasal to the central element (element 30 and 32 in a standard 61 element 
array) were also individually analyzed and the relative difference between the 
temporal versus nasal amplitudes for each eye was also compared. 
 
Optical Coherence Tomography Imaging 
Standard OCT volume scans comprising 128 B-scans within a 6x6 mm area were 
acquired using a Topcon 3D-OCT1000 or 3D-OCT2000 unit (Topcon Medical 
Systems Inc., New Jersey, United States). Segmentation and en-face imaging of the 
photoreceptor ellipsoid zone (EZ) line was performed using 3D image analysis 
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software (Visage Imaging Amira v5.3.3, Richmond, Australia). Image processing and 
calculation of this EZ break area in MacTel has been previously reported.26,27 
Disruption of the external limiting membrane (ELM) layer on OCT was also recorded 
as a surrogate marker of outer retinal dysfunction.28 Scaling of the mfERG waveforms 
for comparison to OCT was made according to the standard 61 hexagon array with 
the central stimulus response accounting for approximately 4.2 – 4.5º. The lower limit 
of 4.2º was used in the conversion of 1º to 0.28 mm for a 6 mm Topcon B-scan. 
 
Statistical Analysis 
All statistical analyses were performed using the Statistical Package for the Social 
Sciences v.20 (IBM SPSS Inc, Chicago IL). T-test was performed to compare the 
means between mfERG amplitudes of patients from a group of healthy controls and in 
patients with and without ELM disruption. Multiple linear regression modelling was 
performed to examine the relationship between the size of the EZ break on en-face 
OCT imaging and presence of intraretinal pigment against the mfERG central 
hexagon response amplitude. The final model included adjustment for age, which 
although not significant on univariate modelling, may affect the electrophysiological 
responses. A value of p < 0.05 was considered significant.  
 
Results 
Patient Characteristics 
A total of 23 patients with MacTel on the registry had electrophysiological studies. 
One was excluded from the final analysis because of unexplained light perception 
visual acuity not consistent with MacTel; the other had been treated with 
hydroxychloroquine for rheumatoid arthritis. Of the remaining 21 patients, the 
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average age was 58.7 ± 10.6 years and the majority were female (n = 15, 71%) (Table 
1). Mean visual acuity at the time of electrophysiological testing was logMAR 0.41 ± 
0.21, equivalent to 20/51 Snellen visual acuity. All 42 eyes were treatment naïve. No 
patients had subretinal neovascularization or macular hole complications secondary to 
MacTel.  
 
Electrophysiology 
Full-field ERG and PERG were performed in all patients. Full-field ERGs 
(comprising ISCEV DA0.01, DA10.0, LA30Hz and LA3.0 responses) were normal 
for age in all 42 eyes (Table 2). Six of 42 eyes (14%) had subnormal PERG P50 
amplitudes either compared to the lower limits of normal for age (n = 5) or as 
compared to the fellow eye with significant interocular asymmetry of more than 30% 
(n = 1) (see Figure 1). With a doubled stimulus field, the P50 amplitude increased by 
a mean 2.85 times (range 2.5 – 3.7) in patients with subnormal response to standard 
field (lower limit of normal enlargement 60%).21 The mean P50 amplitudes for the 
cohort were within normal limits for age (Table 2). 
 
Multifocal ERG responses are displayed in Figure 2. Twenty-two of 30 eyes (73%) 
had reduction in the first positive response (P1) amplitude but accompanied by 
preservation of the first negative (N1) amplitude for the central hexagon, resulting in 
a reduced P1:N1 ratio. The dysfunction was highly localized, affecting the central or 
paracentral responses and sparing the outer elements (Figure 3). When compared to a 
control group, the P1:N1 ratio from the central response was significantly different 
from normal (mean ratio: 2.5 ± 1.0 vs. 3.0 ± 0.4, p = 0.003 respectively) (Table 3). 
The P1:N1 ratio was not statistically different in any other ring. There was reduced 
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paracentral response in 15 eyes (50%): 13 of which were confined to the temporal 
paracentral element and 2 eyes where the dysfunction affected most of the paracentral 
ring (R2).  There was significant asymmetry between temporal and nasal paracentral 
responses, with a mean 26 ±16 % reduction in the temporal P1 amplitude as compared 
to the nasal response (Figure 4). All eyes with a normal mfERG (n=8) also had a 
normal PERG P50 component. 
 
There was no statistically significant difference in the central mfERG P1 response in 
the patients with and without intraretinal pigment migration on multiple linear 
regression analysis controlling for age (central P1 amplitude: B = -0.22, p = 0.17, R2 = 
0.03). There was a trend towards significance for the central P1:N1 ratio (B = -0.46, p 
= 0.07, R2 = 0.11) but the effect size was small. There was also no difference in the 
PERG P50 component between the two groups.  
 
EOGs were normal in all those tested (n= 24 eyes; mean light rise: 258 ± 74%).  
 
Correlation between mfERG and Optical Coherence Tomography 
 
OCT in all patients revealed inner retinal hyporeflective cavitations and/or changes in 
reflectivity in keeping with neurodegeneration and consistent with MacTel. In the 
subset that had mfERG, 27 eyes (90%) had an EZ break on OCT (mean 1.2 ± 1.3 
mm2, range 0 – 4.4 mm2) and 20 eyes (67%) had disruption of the ELM on B-scan. 
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The central and paracentral responses on mfERG were compared against the area of 
EZ loss on OCT (Figure 5). Linear regression modelling examined the correlation 
between the EZ break size on imaging and the mfERG response. Age and eye 
laterality were not significant predictors on univariate analysis. Increasing size of the 
EZ break area was significantly associated with decreasing central hexagon P1 
amplitudes on multiple regression analysis controlling for age (R2 = 0.37, Beta 
coefficient = - 0.26, p = 0.002). Similarly, increasing size of the EZ break area was 
also predictive of a greater decrease in central P1:N1 ratio (R2 = 0.32, Beta coefficient 
= - 0.51, p = 0.002), Figure 6. There was no significant association with any of the 
ring averaged peripheral responses. Further analysis of the five eyes that had either no 
EZ break on any slice (n=3) or only a very small EZ break with an area < 0.05mm2 
(n=2) revealed evidence of subnormal central stimulus in all but one, with mean 
central P1 amplitude of 1.1 ± 0.4 µV but less apparent reduction in the P1:N1 ratio 
(2.8 ± 0.7 µV).  
 
The localized reduction in the first positive response and preservation of the first 
negative response was even more pronounced in patients with concurrent outer retinal 
disease as assessed by disruption of the ELM (n = 20, 67%) (Figure 7). The mean 
P1:N1 ratio of the central hexagon was 2.8 ± 0.6 when the ELM was intact vs. 2.2 ± 
0.7 when the ELM was disrupted, t(28) = 2.5, p = 0.02). However, there was no 
difference in the absolute amplitude of the first positive response (P1) between eyes 
with or without an intact ELM (mean 1.3 ± 0.4 µV vs. 1.1 ± 0.4 µV, t(28) = 1.1, p = 
0.28). No significant difference in responses was present in the periphery.  
 
Discussion 
 12 
This study provides comprehensive functional assessment of MacTel using 
electrophysiology, significantly extending previous limited reports. It further 
demonstrates a novel structure/function correlation between electrophysiological 
parameters and structural neurodegeneration as shown on OCT imaging.   
 
In the early descriptions of the disease by Gass and Oyakawa17, three patients from 
group 3 idiopathic juxtafoveolar telangiectasia (equivalent to MacTel type 2) had 
ERG and EOG performed. Data and protocol were not detailed but results were 
reported to be normal. In contrast, a later case was described of a patient with MacTel 
who was initially presumed to have a cone dystrophy due to cone dysfunction on 
electrophysiology (reduced LA30Hz and LA3.0 ERG).18 The present results are in 
keeping with the original 3 cases presented by Gass and Oyakawa with full-field 
electroretinography normal in every patient, and thus, no evidence of generalized 
retinal dysfunction. Similarly, the preserved EOG light rise suggests there to be no 
generalized disturbance of RPE function. Pattern ERG P50 was mildly subnormal in a 
small proportion of patients to standard field stimulus but showed normal enlargement 
to a large field stimulus, in keeping with the mfERG evidence of localized central 
macular dysfunction.  
 
In the majority of cases, mfERGs showed preservation of the early negative 
component (N1) in the response to the central stimulus element but selective 
reduction of the positive component (P1); in healthy normal subjects, the central 
response is usually the largest in the array. The temporal paracentral response was 
also affected in half of the patients, with significant asymmetry between temporal and 
nasal response. Peripheral mfERG responses were unaffected. These data support the 
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concept of MacTel having localized disturbance of macular function, and uniquely 
provide evidence of an inner retinal site of dysfunction.  
 
Understanding of the pathological MacTel area has increased with the advent of 
advanced imaging techniques. The initial classification of MacTel in the early1990s 
described a juxtafoveal area of telangiectasis as seen on biomicroscopy and 
paracentral late phase hyperfluorescence on fluorescein angiography.2 More recently 
however, confocal BLR imaging has revealed a characteristic pattern of oval 
paracentral hyper-reflectance that is usually slightly larger than the angiographic area 
of leakage.4,29 This reflectance phenomenon shares topographic correlation with the 
focal area of central macular pigment reduction seen with dual wavelength 
autofluorescence.5 Evidence for this discrete MacTel area is also present from 
histopathology; a marked area of macular pigment loss centrally was present on 
macroscopic pathological examination of a donor MacTel eye.7 There was reported to 
be an oval boundary with an approximate 6.5° horizontal by 5° vertical 
dimension,1,5,30 consistent with measurements of abnormal annular macular pigment in 
MacTel on dual wavelength autofluorescence (median peak optical density at 
approximately 5.2° eccentricity). This is also in keeping with the present mfERG 
data, showing dysfunction confined to the central or paracentral area (the central 
response element corresponds to ~4.5° horizontal diameter in a 61 element array).  
 
There was also significant temporal and nasal asymmetry in this cohort. In eyes with 
paracentral involvement, the temporal paracentral element was a mean 25% lower in 
P1 amplitude when compared to the nasal side. An epicentre of the disease temporal 
to the fovea is also suggested from previous studies with retinal changes presenting 
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temporally initially on fundus examination,31 as well on imaging1,32 and functional 
assessment with microperimetry.10 This asymmetry and localized temporal paracentral 
involvement may also explain the normal results for R2 in this cohort as compared to 
normals, as the dysfunction is diluted out when taking averages of all the responses in 
the paracentral ring. The focal reduction in the temporal paracentral response is all the 
more striking as previous studies have suggested that the naso-temporal difference is 
reversed in normal eyes, with the temporal response usually slightly greater than the 
nasal.33,34   
 
The highly localized nature of the disease also explains the normal PERG response in 
the majority of the patients, since the PERG arises from a 15x12° central area35 and 
lacks the spatial resolution of the mfERG to detect small localized areas of 
dysfunction. However, it should be noted that mfERG testing is highly dependent on 
the ability of the patient to fixate accurately and PERG may prove informative in 
patients unable to fixate optimally. 
 
Yellow foveal subretinal deposits have been described in a small case series of 
MacTel patients.17,36 The material consisted of degenerate photoreceptor outer 
segments on electron microscopy with corresponding hyperautofluorescence on 
imaging. Unlike foveomacular vitelliform dystrophy, there was no reported associated 
retinal pigment epithelium (RPE) reaction microscopically. More widespread 
subretinal deposits have also been reported on histologic examination, consisting of 
photoreceptor outer segments and RPE proteins.37 None of the present patients, 
however, had evidence of any yellow lesion on fundoscopy or on imaging. The 
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normal EOGs and full-field ERGs in the present cohort argue against widespread RPE 
dysfunction and support the subclinical nature of these histologic findings. 
 
The finding of a reduced P1:N1 ratio in the central mfERG recording, resulting from a 
selective reduction in the positive component of the response, suggests inner retinal 
dysfunction localized to the central macula.33,38,39 Although the exact pathogenesis of 
the disorder is still to be determined, immunohistochemitry in confirmed cases of 
MacTel showed central loss of reactivity of Müller cell markers in the same 
distribution as the macular pigment loss.7,40 It was hypothesized that MacTel may be a 
primary Müller cell disorder7,36 and that the neurodegenerative features of this disease 
may be a consequence of the Müller cell role in neuroprotection and recycling of 
toxic neurotransmitters.41,42 
 
The mfERG P1 amplitudes and P1:N1 ratios correlated with the size of EZ disruption 
on en-face OCT in this study. Natural history studies have demonstrated progressive 
neurodegeneration in MacTel as evidenced by expansion in the area of EZ 
hyporeflectivity on OCT imaging.27 The electrophysiological responses here support 
data from previous microperimetry studies,26,27 additionally providing objective 
structure-function correlation and localising dysfunction to a level that is inner retinal. 
It may also give an indication of the lateral extent of inner retinal dysfunction as 
reduction in central mfERG response was seen even in eyes without an EZ break.  
 
It has recently been reported that localised visual function may still be present in 
MacTel eyes in areas where cones are not visualized on imaging. Using adaptive 
optics scanning laser ophthalmoscopy (AOSLO) and AOSLO integrated 
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microperimetry (AOMP), retinal sensitivity was shown to be retained, albeit at a 
higher threshold, in some areas of EZ hyporeflectivity on OCT imaging if the ELM 
was intact.28 Interestingly, in the present cohort, evidence of ELM disruption was 
associated with even greater reduction in the P1:N1 amplitude in the central hexagon 
compared to those with an intact ELM layer. Typically, a normal P1:N1 ratio would 
be expected in primary photoreceptor disease.38 The finding here of a reduced P1:N1 
ratio therefore suggests that even in the presence of photoreceptor abnormalities on 
imaging, the primary pathology in these patients is post-synaptic to photoreceptors. 
The greater reduction in the ratio seen in patients with an ELM break may reflect the 
patients with more advanced disease and therefore greater inner retinal dysfunction.  
Similarly there was no direct correlation between presence of intraretinal pigment 
migration and the mfERG central response amplitude. There was a trend however 
towards reduced central P1:N1 ratio. Larger number of patients may determine if this 
is significant.  
 
The localized findings in the present cohort are in contrast with the only other 
reported mfERG data in MacTel19. Those authors published results from 14 patients 
with a diagnosis of MacTel based on clinical examination and fundus fluorescein 
angiogram. Patients underwent mfERG studies only, using a similar 61-stimulus 
array. Global macular dysfunction was described and reduction in amplitudes was 
reported in both P1 and N1 components. The greatest changes were seen in the central 
responses < 2° but both N1 and P1 were reported abnormal even in eccentric 
responses. The difference in outcomes between the two studies may be due to 
differences in study population. The present cohort had MacTel confirmed by 
multimodal imaging including not only fluorescein angiography but also SD-OCT 
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and autofluoresence. It should be noted that those authors acknowledged technical 
difficulties and the presence of artefacts, and further interpreted the result as 
percentage reduction instead of assessment of each waveform. Those factors may be 
relevant given the known dependence of any electrophysiological measure, but 
particularly mfERG, on technical factors and fixation. 
 
A limitation of this study is that as it was retrospective, not all patients in the series 
had mfERG or EOG performed. However the subset who had additional mfERG 
testing covered the spectrum of MacTel disease severity from small inner retinal 
hyporeflective cavities without outer retinal pathology to patients with severe foveal 
atrophy and intraretinal pigment migration. Further, it also included patients who had 
both normal and subnormal responses on initial PERG. 
 
Conclusion 
This study provides a comprehensive electrophysiological characterization of retinal 
and macular function in MacTel. The majority of cases show dysfunction, detected in 
most by mfERG testing and invariably confined to the central macular area. The 
nature of the mfERG changes support an inner retinal site of dysfunction, potentially 
related to abnormal Müller cell function, and the size of the mfERG response can be 
correlated with structural changes of ellipsoid zone loss evident on OCT. In contrast 
with previous reports, no generalized mfERG abnormalities were detected in this 
cohort. The study highlights the utility of mfERG testing in MacTel, showing high 
sensitivity and exposing evidence of highly localized inner retinal dysfunction, not 
revealed by PERG.  
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Dual-wavelength autofluorescence for macular pigment optical density mapping is 
not readily available and patients are often referred for electrophysiological testing 
with unspecified macular pathology and the diagnosis of MacTel not necessarily 
suspected. Although the pattern of reduced positivity in the central and temporal 
paracentral hexagons on mfERG is not disease specific, such findings may be a useful 
non-invasive adjunct to multimodal imaging in cases of diagnostic uncertainty. 
Furthermore, electrophysiological testing may be a useful objective method of 
assessing function for monitoring of disease progression in an individual patient or as 
an endpoint in therapeutic clinical trials.   
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Table	  1.	  Patient	  Demographics	  	  
Characteristic Value 
Patients (n) 21 
Eyes (n) 42 
Age (y)  
Mean ± SD 58.7 ± 10.6 
Range 39  – 74 
Female, n (%) 15 (71) 
Best corrected visual acuity   
Mean ± SD (LogMAR) 0.41 ± 0.21  
Mean Snellen Acuity 20/51 
LogMAR Range (Snellen) -0.08 – 1.00 (20/17 – 20/200) 	  SD:	  standard	  deviation;	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Table	  2.	  	  Summary	  of	  electrophysiological	  responses	  in	  MacTel	  patients	  performed	  according	  to	  ISCEV	  standard.	  Normal	  limits	  for	  the	  two	  age	  groups	  are	  defined	  as	  the	  minimum	  normal	  amplitude	  minus	  5%	  of	  the	  reference	  interval	  (maximum	  normal	  value	  –	  minimum	  normal	  value)	  in	  a	  healthy	  cohort.	  	  	  
 MacTel  
(m±SD µV) 
Normal Limits 
(µV) 
ERG 
Age < 50 (n =10) 
DA 0.01  289 ± 53 (235 – 365)  > 140 
DA 10.0 a-wave 354 ± 45 (260 – 410) > 240 
DA 10.0 b-wave  575 ± 98 (415 – 700) > 350 
LA 3.0 b-wave  166 ± 29 (120 – 205) >101 
LA 30Hz flicker 107 ± 14 (85 – 135) > 70 
Age ≥ 50 (n = 32) 
DA 0.01  220 ± 71 (100 – 370) > 80 
DA 10.0 a-wave  309 ± 54 (180 – 400) > 150 
DA 10.0 b-wave  452 ± 72 (240 – 645) > 200 
LA 3.0 b-wave  143 ± 31 (99 – 190) > 95 
LA 30Hz flicker 104 ± 29 (65 – 170) > 62 
PERG   
Age < 50 (n = 10) 
P50 amp 
 
2.7 ± 0.5 (2.1 – 3.7) 
 
> 2.0 
Age ≥ 50 (n = 32) 
P50 amp 
 
2.3 ± 0.7 (1.0 – 4.2) 
 
> 1.5 
EOG   
Number of eyes (%) 24 (57)  
Light rise %, m±SD 258 ± 74 > 180 	  µV:	  microvolts;	  ERG	  :	  full-­‐field	  electroretinogram	  ;	  DA:	  dark-­‐adapted;	  LA:	  light-­‐adapted;	  PERG	  :	  pattern	  electroretinogram;	  EOG	  :	  electrooculogram	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Table	  3.	  Central	  multifocal	  electroretinogram	  responses	  in	  MacTel	  compared	  to	  a	  healthy	  control	  cohort	  	  
Parameters MacTel 
(n = 30) 
Controls 
(n = 12) 
P-value 
Central stimulus N1 amplitude, m±SD (µV) 0.4 ± 0.2 0.7 ± 0.1 0.08 
Central stimulus P1 amplitude, m±SD (µV) 1.2 ± 0.5 2.4 ± 0.7 < 0.01* 
Central P1:N1 ratio, m±SD 2.5 ± 1.0  3.0 ± 0.4 <0.01* 
Central stimulus N1 latency, m±SD (ms) 19.0 ± 3.7 18.2 ± 2.0 0.49 
Central stimulus P1 latency, m±SD (ms) 39.4 ± 5.9 42.7 ± 2.7 0.08 	  m:	  mean;	  SD:	  standard	  deviation;	  µV:	  microvolts	  ;	  ms	  =	  millisecond	  	  	  	   	  
 26 
Figure 1.  
Pattern electroretinogram P50 amplitudes in MacTel 2 compared to controls 
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Figure 2.  
Multifocal electroretinogram of the right eye of a 62 year old female with MacTel 2 
demonstrating preserved first negative response (N1) and reduced first positive 
response (P1) in central element (arrow). Inset - Enlarged view of above comparing 
central element waveform (left) and a more peripheral waveform (right). In healthy 
subjects, the central element is usually the largest.  
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Figure 3.  
Multifocal electroretinography (mfERG) P1:N1 ratio by rings in MacTel patients 
compared to control group. Results displayed as boxplot.  
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Figure 4.  
Multifocal electroretinogram of the right eye of a 74 year old man with MacTel 2 
revealing temporal parafoveal reduction compared to nasal parafoveal response. 
Corresponding fundus image with area of ellipsoid zone loss outlined on enface 
imaging.  
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Figure 5.  
Mapping of multifocal electroretinogram central and paracentral stimulus elements 
against optical coherence tomography scans in a 70 year old female. Left: En-face 
image of area of ellipsoid zone break; Right: Corresponding B-scan image with scaled 
waveforms (1mm = 3.57°) 
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Figure 6.  
Correlation between ellipsoid zone break with (A) central response P1 amplitude in 
multifocal electroretinography (mfERG) and (B) central response P1:N1 ratio. 
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Figure 7.  
64 year old female with MacTel 2. Left visual acuity 20/120 with outer retinal atrophy 
on optical coherence tomography. Multifocal electroretinogram demonstrates reduced 
P1:N1 ratio in central element.   
 
 
 
 
 	  	  	  
 
 
 
 
 
 
